Markets:

Overview

News

Currencies

International

Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

23.95 +0.91 (+3.97%)

Streaming Delayed Price Updated: 11:38 AM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Legend Biotech Corporation - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

The FDA Shake-Up Continues, And Could Impact Genetic Medicines ↗

June 20, 2025

Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.

Via Investor's Business Daily

Topics Government

Is Legend Biotech Gaining or Losing Market Support? ↗

June 12, 2025

Via Benzinga

Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday ↗

June 10, 2025

Via Benzinga

Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday ↗

June 06, 2025

Via Benzinga

What Does the Market Think About Legend Biotech? ↗

April 29, 2025

Via Benzinga

Is Legend Biotech Gaining or Losing Market Support? ↗

March 05, 2025

Via Benzinga

Peering Into Legend Biotech's Recent Short Interest ↗

February 17, 2025

Via Benzinga

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

June 03, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

May 22, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 19, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Where Legend Biotech Stands With Analysts ↗

January 23, 2025

Via Benzinga

Breaking Down Legend Biotech: 9 Analysts Share Their Views ↗

December 30, 2024

Via Benzinga

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

May 13, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results

April 29, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday ↗

April 15, 2025

Via Benzinga

(LEGN) - Analyzing Legend Biotech's Short Interest ↗

December 16, 2024

Via Benzinga

Deep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings) ↗

December 10, 2024

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst ↗

April 08, 2025

Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.

Via Benzinga

Topics World Trade

5 Analysts Have This To Say About Legend Biotech ↗

April 08, 2025

Via Benzinga

What Does the Market Think About Legend Biotech? ↗

April 03, 2025

Via Benzinga

Demystifying Legend Biotech: Insights From 5 Analyst Reviews ↗

March 17, 2025

Via Benzinga

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

March 11, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results

February 25, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 19, 2024

From Legend Biotech USA Inc.

Via GlobeNewswire

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

December 09, 2024

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

November 12, 2024

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

November 07, 2024

From Legend Biotech USA Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.